The PROMISE of Early Detection and Interception in Myeloma

Yale Cancer Center Grand Rounds | February 28, 2023Подробнее

The added value of early detection and interception in patients with myelomaПодробнее

The Promise Study: How a Blood Test Can Detect, Intercept, and Potentially Eliminate CancerПодробнее

What is the PROMISE study? #myelomaПодробнее

PROMISE: why early detection of MGUS is vital to reducing MM incidenceПодробнее

Recent updates from the PROMISE studyПодробнее

The PROMISE Study: Screening for Multiple Myeloma in High-Risk IndividualsПодробнее

The promise of early detectionПодробнее

We're showing how we're changing the face of myeloma with early detection and intervention.Подробнее

The Promise of Prevention. Multiple Myeloma and The Promise StudyПодробнее

Early identification of myeloma to prevent disease progressionПодробнее

Early myeloma screening: an update on PROMISEПодробнее

iStopMM study —early detection and intervention could prevent myeloma and its complications.Подробнее

Smoldering multiple myeloma: Early detection and intervention approaches by Dr. Mark BustorosПодробнее

The promise of elranatamab and other bispecifics in the treatment of myelomaПодробнее

First results of PROMISE: MGUS screening in a high-risk populationПодробнее

Myeloma: why PROMISE?Подробнее

The PROMISE Study #myelomaПодробнее

Smoldering Multiple MyelomaПодробнее